GOLDMAN SACHS GROUP INC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 886982
NEW YORK, NY
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,717,529
-$828,665 QoQ
Shares Held
2,020,329
+0.3% QoQ
Ownership
0.782%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 98.76361721284009.ToString("F0")%
Shared 0.8359529561769395.ToString("F0")%
None 0.4004298309829736.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. MRVI ranks #173 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,717,529 | 2,020,329 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,546,194 | 2,014,214 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $4,512,084 | 1,572,155 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,282,821 | 1,362,167 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,126,866 | 1,414,872 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $8,789,982 | 1,612,841 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $16,940,333 | 2,038,548 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,010,040 | 420,397 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,727,644 | 199,267 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,320,007 | 201,528 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,413,020 | 241,302 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,017,524 | 162,311 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $5,293,719 | 377,853 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $13,842,005 | 967,296 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $9,689,936 | 379,551 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $9,241,033 | 325,274 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $9,996,503 | 283,428 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,211,027 | 315,299 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,882,728 | 119,860 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $5,718,178 | 137,028 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,641,325 | 130,228 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,428,260 | 86,569 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||